Health · Article 13 · the US
Federal Law 2/2019
Health-data localization (Article 13) and Cabinet Decision 32/2020 met by in-country deployment.
The patient record has a jurisdiction, and the AI has to stay in it. Iftah keeps diagnostic, clinical, and life-sciences AI inside the hospital, the national cloud, or the bare-metal suite where that record legally lives. One control plane governs every model, prompt, and access decision across the US — PHI, genomics, and imaging never transit an unmanaged external model.
Read moreاقرأ المزيدShow lessعرض أقلThe patient record has a jurisdiction, and the AI has to stay in it. Iftah keeps diagnostic, clinical, and life-sciences AI inside the hospital, the national cloud, or the bare-metal suite where that record legally lives. One control plane governs every model, prompt, and access decision across the US — PHI, genomics, and imaging never transit an unmanaged external model.
Built for US health-data localization
Frameworks we map to
Iftah does not certify compliance — that stays the provider's obligation. In-jurisdiction deployment, clinical guardrails, and a per-inference audit trail give your DPO and regulators concrete evidence.
Health · Article 13 · the US
Health-data localization (Article 13) and Cabinet Decision 32/2020 met by in-country deployment.
Data · NIST AI RMF · the US
Health data as sensitive personal data, with cross-border transfer controls enforced.
Devices · the FDA · the US
Model-version, change-control, and audit evidence for AI/ML software-as-a-medical-device.
Cyber · NIST · the US
Access, logging, and segmentation aligned to Essential and Cloud Cybersecurity Controls.
Health authorities · the US
Aligned to DHA Health Information Protection & Confidentiality policy and emirate authorities.
Data · HIPAA · US
MOPH, NHRA (with mandated DPO), and Oman's health-data permit requirements respected in-region.
The trade you can't afford → Iftah's answer
Residency
SaaS AI routes protected health information to multi-tenant endpoints abroad — violating Article 13 and sensitive-data privacy rules.
Iftah approach
Every model and inference endpoint is pinned to a chosen jurisdiction and provider, with enforceable, auditable residency proof.
Safety
Generic chatbots offer no PHI redaction, no provenance, and no audit trail acceptable to the FDA or a Data Protection Officer.
Iftah approach
Clinical-safety guardrails — PHI redaction, hallucination controls, retrieval grounding, mandatory human-in-the-loop — apply across every deployment.
SaMD
Hospitals can't prove which model version or prompt produced a recommendation, undermining FDA SaMD change control.
Iftah approach
An immutable, per-inference record of model version, policy, data lineage, and approver aligns with SaMD and DPO obligations.
IP
Trial data, molecule libraries, and manufacturing parameters are exposed the moment they transit an unmanaged external model.
Iftah approach
Training and fine-tuning stay private to the institution; proprietary data never feeds a shared model.
Governance
A multi-country health group ends up with fragmented, ungovernable AI per entity.
Iftah approach
One control plane standardizes governance across all your entities.
How it deploys for healthcare
From the national health cloud to a bare-metal cluster in the radiology suite — one governance standard across all of it.
Sovereign cloud
Patient-facing and administrative AI on an approved in-country health cloud.
Multi-cloud & hybrid
EMR-adjacent workloads across in-region hyperscaler and private infrastructure.
On-prem
Real-time imaging triage and OR decision support on GPUs where imaging never leaves the building.
Disconnected
Genomic pipelines and pharma R&D on isolated clusters with no external path.
What teams ship
Critical-finding flags in-region while imaging stays on the hospital's bare-metal cluster.
multilingual-English scribing inside the EMR boundary with PHI redaction and clinician sign-off.
Retrieval over national formularies, the FDA labels, and protocols with cited, governed sources.
Integrated with national health records, answering only from authorized, in-jurisdiction data.
Trial-document review, adverse-event coding, and dossier drafting without external exposure.
Capacity, no-show prediction, and revenue cycle under one residency and access policy.
Next step